Phase II Studies of Polymer-Doxorubicin (PK1, FCE28068) in the Treatment of Breast, Lung and Colorectal Cancer

International Journal of Oncology - Greece
doi 10.3892/ijo_00000293
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Spandidos Publications

Related search

Doxorubicin and 5-Fluorouracil Versus Doxorubicin and Oral Ftorafur in the Treatment of Advanced Gastric Cancer—a Phase II and III Trial

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1990English

Phase I/Ii Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination With Doxorubicin and Docetaxel in Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

Phase II Trial of UFT in Advanced Colorectal and Gastric Cancer

British Journal of Cancer
Cancer ResearchOncology
1990English

Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008)

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2018English

Prognostic Factors in the Treatment of Lung Metastases From Colorectal Cancer

Siberian Journal of Oncology
Cancer ResearchOncology
2018English

Cost of Disease Progression in Patients With Metastatic Breast, Lung, and Colorectal Cancer

Oncologist
Cancer ResearchMedicineOncology
2019English

Bioactive Graft Co-Polymer for the Treatment of Breast Cancer

2019English

EO9 Phase II Study in Advanced Breast, Gastric, Pancreatic and Colorectal Carcinoma by the EORTC Early Clinical Studies Group

European Journal of Cancer
Cancer ResearchOncology
1996English

A Phase II Study of Oxaliplatin, Dose-Intense Capecitabine, and High-Dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy